A Biocatalytic Platform for Synthesis of Chiral α-Trifluoromethylated Organoborons by Huang, Xiongyi et al.
 A biocatalytic platform for synthesis of chiral α-trifluoromethylated 
organoborons  
 
Xiongyi Huang,†§ Marc Garcia-Borràs,†‡ Kun Miao,§ S. B. Jennifer Kan,§ Arjun Zutshi,§ K. N. Houk,*‡ 
and Frances H. Arnold*§ 
 
§Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 
91125 
‡Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095 
 
Abstract: There are few biocatalytic transformations that produce fluorine-containing molecules prevalent 
in modern pharmaceuticals. To expand the scope of biocatalysis for organofluorine synthesis, we have 
developed an enzymatic platform for highly enantioselective carbene B–H bond insertion to yield versatile 
α-trifluoromethylated (α-CF3) organoborons, an important class of organofluorine molecules that contain 
stereogenic centers bearing both CF3 and boron groups. In contrast to current ‘carbene transferase’ enzymes 
that use a limited set of simple diazo compounds as carbene precursors, this system based on Rhodothermus 
marinus cytochrome c (Rma cyt c) can accept a broad range of trifluorodiazo alkanes and deliver versatile 
chiral α-CF3 organoborons with total turnovers up to 2870 and enantiomeric ratios up to 98.5:1.5. 
Computational modeling reveals that this broad diazo scope is enabled by an active site environment that 
directs the alkyl substituent on the heme CF3-carbene intermediate towards the solvent-exposed face, 




       
      Fluorine-containing molecules have assumed a privileged position in modern medicine and comprise 
more than 20% of all pharmaceuticals.1-2 Although many chemical methods for synthesis of organofluorines 
have been developed,3-4 there is a noticeable lack of enzymatic approaches for their synthesis.5 To expand 
the scope of biocatalytic fluorine chemistry, two main strategies are currently considered.5-6 The first is to 
expand the substrate scope of natural fluorinase enzymes via protein engineering. The second is to modify 
biosynthetic pathways to accept fluorinated building blocks for precursor-directed biosynthesis. Although 
significant progress has been made,5-13 both approaches suffer from restricted substrate scope and low 
efficiency, which hampers synthetic applications.  
       A promising strategy to expand the synthetic capability of nature is to introduce non-natural chemistries 
into existing proteins.14-16 Enzymes that share similar mechanistic elements with non-natural reactions can 
exhibit promiscuous activities for abiological reactions, from which new activities can be evolved.17-18 Here, 
we used this mechanism-driven approach to develop fully genetically encoded enzymes that can perform 
non-natural reactions for organofluorine synthesis. Our target transformation is the synthesis of chiral α-
trifluoromethylated (α-CF3) organoborons from trifluorodiazo alkanes and Lewis-base borane complexes. 
This class of organofluorine compounds serve as valuable synthetic building blocks that can be converted 
to a broad range of CF3-containing molecules via versatile boron-mediated transformations.19-24 Despite the 
synthetic versatility of α-CF3 organoborons, their asymmetric preparation remains a challenge. The few 
known enantioselective examples in synthetic chemistry include a copper-catalyzed asymmetric 
hydroboration of CF3-substituted alkenes and enantioselective insertions of CF3-carbene intermediates into 
B–H bonds of Lewis-base borane complexes.21,25 The substrate scopes in both examples are very limited: 
the hydroboration approach can only be applied to aromatic β-CF3-α,β-unsaturated ketones,21 whereas the 
B–H insertion strategy has only been demonstrated with a few aryl substituted trifluorodiazo compounds.25   
      The deficit of methods for making chiral α-CF3 organoborons motivated us to develop an enzymatic 
platform for their synthesis by reprogramming heme proteins to utilize trifluorodiazo alkanes for highly 
enantioselective carbene B–H bond insertion reactions (Figure 1a). Harnessing the facile synthetic 
accessibility of trifluorodiazo alkanes26 and the evolvability of heme proteins,16,27 this platform can be used 
to prepare a broad range of chiral α-CF3 organoborons, many of which are currently unobtainable. The 
major challenge to developing the enzymatic system is engineering the heme proteins to accommodate 
structurally diverse heme CF3-carbene intermediates for enantioselective B–H bond insertion. Although 
current carbene transferases can use a variety of substrates for versatile chemical transformations,28-43 the 
scope of diazo compounds in most of these reactions has been very limited (mainly to ethyl diazoacetate 
(EDA)). To expand the diazo substrate scope, it has usually been necessary to re-optimize the enzyme active 
site for each new diazo substrate. Furthermore, for all synthetic carbene B–H bond insertion reactions 
developed to date,44-50 high enantioselectivity has only been achieved for diazo compounds containing 
(hetero)aromatic groups adjacent to the diazo carbon.    
      We envisioned that these challenges could be met by leveraging the unique structural features of 
Rhodothermus marinus cytochrome c (Rma cyt c).51 This protein has proven to be a highly versatile 
platform for developing new enzymatic carbene-transfer reactions.33-34 The heme-binding pocket of wild-
type Rma cyt c is surrounded by several α-helices, two of which are connected by a surface loop.51  Recent 
structural characterization of the laboratory-evolved Rma cyt c TDE carbene transferase with a bound iron 
porphyrin carbene (IPC) intermediate revealed that the three mutations introduced during directed evolution 
rendered this surface loop (residues 98-103) highly flexible (Figure 1b, left).52 This enhanced flexibility 
allows the loop to explore more open conformations, not observed in the wild-type structure, that promote 
interactions between the substrate and the carbene intermediate. We hypothesized that we could engineer 
an active site environment that favors a constrained conformation in which the CF3 group of heme CF3-
carbene intermediates point into the heme pocket, and the bulkier alkyl substituent R faces the solvent-
exposed side (Figure 1b, right). In this conformation, the restricted orientation of the CF3 group could ensure 
highly enantioselective formation of C–B bonds with little or no interference from the alkyl substituent R.  
 
Figure 1. (a) Design of a general enzymatic platform for synthesis of chiral α-CF3 organoborons. (b) On the left, 
overlay of Rma cyt c (3CP5.pdb, front loop region in blue ), Rma TDE (6CUK.pdb, front loop region in orange) and 
Rma TDE with iron porphyrin carbene structure obtained from computational modeling (Ref. 52, front loop region in 
green). The large change in front loop structure highlights the impact loop mutations have on access to the active of 
Rma cyt c. On the right, we propose that the active-site environment can be tuned to orient the heme-carbene 
intermediate such that the alkyl substituent R is solvent-exposed.  
 
      To identify mutations that can stabilize the conformation proposed in Figure 1b, we began directed 
evolution of Rma cyt c with N-heterocyclic carbene (NHC) borane 1 as the model borane substrate and (3-
diazo-4,4,4-trifluorobutyl)benzene (2 in Figure 2) as the model diazo carbene precursor. We expected that 
the large phenylethyl group in 2 would facilitate its positioning toward the solvent-exposed face. While 
wild-type Rma cyt c barely catalyzes carbene B–H insertion with 2, site-saturation mutagenesis (SSM) at 
residue V75 led to the discovery of the V75S variant, which afforded the desired product 2a with 220 total 
turnovers (TTN) and 80:20 enantiomeric ratio (e.r.). Residue V75 is located on an α-helix that is close to 
the heme cofactor and was previously shown to be a key site for expanding the scope of diazo compounds.33 
With Rma cyt c V75S as the parent, we performed additional rounds of SSM on residues M100, M103, 
T101, and M99 to further improve the catalytic performance of this borylation catalyst. These residues 
reside on the front loop and are important for controlling the structure of the heme pocket.52 Through this 
engineering, we obtained a quadruple mutant, Rma cyt c V75S M100L M103D M99A (SLDA), which 
produced product 2a with 1960 TTN and 96.5:3.5 e.r..  
      Y44 on the A helix of Rma cyt c is another residue that might affect catalysis of the target borylation 
reaction. In an Rma cyt c-catalyzed carbene Si–H insertion reaction, this residue was expected to interact 
with a silane substrate approaching the enzyme active site, as indicated by the crystal structure of an Rma 
cyt c-bound heme-carbene intermediate.52 SSM of the quadruple mutant SLAD at Y44 and screening 
yielded the Y44I mutation that further improved borylation activity to 2460 TTN and enantioselectivity to 
97.5:2.5 e.r..   
 
Figure 2. (a) X-ray crystal structure of wild-type Rma cyt c (PDB: 3CP5). Residues targeted for site-saturation 
mutagenesis (V75, M99, M100, M103, and Y44) are shown in sticks. (b) Directed evolution of Rma cyt c for 
enantioselective synthesis of α-CF3 organoborons with NHC borane 1 and diazo compound 2 as the model substrates. 
Reactions were performed in M9-N (pH 7.4) suspensions of E. coli cells expressing Rma cyt c variants (OD600 = 20). 
Standard reaction conditions were 10 mM borane substrate 1, 7.5 mM diazo substrate 2, room temperature under 
anaerobic conditions. Total turnovers (TTN) were defined as the amount of α-CF3 organoboron product divided by 
the total amount of expressed Rma cyt c protein as determined by the hemochrome assay. The absolute configuration 
of product 2a was determined to be R based on the optical rotation of the derivatized alcohol. See supplementary 
information for detailed experimental procedures. wt refers to wild-type Rma cyt c.  Single-letter abbreviations for the 
amino acid residues: V, Val; S, Ser; M, Met; L, Leu; D, Asp; A, Ala; Y, Tyr; I, Ile.  
 
      With optimized variant Rma cyt c Y44I V75S M99A M100L M103D (denoted as BOR-CF3) in hand, 
we next probed its activity toward a panel of structurally diverse trifluorodiazo alkanes. If BOR-CF3 
stabilizes the “solvent-exposed” conformation of the R group as we expect, then it should accept a wide 
range of trifluorodiazo alkanes for enantioselective carbene B–H insertion. Indeed, as shown in Figure 3a, 
BOR-CF3 could be used to synthesize a spectrum of α-CF3 organoborons with diverse structural features. 
High enantioselectivity and activity were obtained for diazo compounds bearing different phenyl 
substitution patterns (3a - 6a). Extending the chain length of the alkyl substituent R has a more profound 
impact on the performance of BOR-CF3 (7a - 8a). Strikingly, reducing the chain length to one carbon in 9a 
abolishes borylation activity. As indicated by computational modeling, the iron-carbene intermediate 
generated from diazo 9 with a shorter alkyl chain can adopt conformations in which the phenyl moiety is 
close to the carbene reaction center. Unfavorable steric interactions with the phenyl group in these 
conformations would inhibit the borane substrate’s approach to the carbene (see Figure S6 in the SI). 
 
 
Figure 3. (a) Scope of trifluorodiazo alkanes for carbene B–H insertion catalyzed by BOR-CF3. Reactions were 
performed in M9-N (pH 7.4) suspensions of E. coli cells expressing BOR-CF3 (OD600 = 20). Standard reaction 
conditions were 10 mM borane substrate 1, 7.5 mM diazo substrate n, room temperature under anaerobic conditions. 
The absolute configuration of 2a was determined to be R based on the optical rotation of the derivatized alcohol (see 
supporting information).  (b) Preparative scale synthesis at 0.2 mmol scale and the derivatization of 2a to boronic acid 
2c. 
 
      We further challenged BOR-CF3 with trifluorodiazo alkanes containing alkyl chains without aromatic 
groups (10 - 13). Although these diazo compounds are structurally distinct from the model compound 2 
used for directed evolution, BOR-CF3 can still effectively convert them into α-CF3 organoborons with 730 
- 1630 TTN and 96:4 - 98:2 e.r. (10a - 13a). This result shows that the high enantioselectivity of BOR-CF3 
does not require specific recognition of the aromatic substituent. One synthetic advantage of this method is 
that the trifluorodiazo alkane starting compounds can be synthesized easily from a variety of starting 
materials such as alkyl halides, aldehydes, and carboxylic acids.26,53-54 As these compounds are widely 
present in nature, this method could provide a facile way to obtain chiral organoborons that contain motifs 
of complex natural products. To demonstrate this, we synthesized trifluorodiazo compound 13 bearing a 
geranyl structural motif. Subjecting 13 to the standard conditions described in Figure 3 with BOR-CF3 as 
the catalyst afforded organoboron product 13a with 1630 TTN and 98:2 e.r.. Given the prevalence of the 
geranyl structural motif in bioactive molecules,55 this organoboron compound may find applications in 
syntheses of fluorinated analogues of natural products such as pheromones. To further demonstrate the 
synthetic utility of our method, we performed this biocatalytic transformation on preparative scale and 
obtained borane product 2a in 52% isolated yield and 97:3 e.r.. The NHC borane 2a can be readily converted 
to the boronic acid 2c while retaining the stereochemistry of the boron-substituted chiral center, which 
would facilitate its further derivatization to other chiral trifluoromethyl-containing molecules.  
      We next used molecular dynamics (MD) simulations to obtain further insights into the stereocontrol 
imposed by the enzyme and the roles of the introduced mutations. Analysis of the active site shape of BOR-
CF3 in the absence of both substrates revealed that the hydroxyl group in the 75S side chain forms a 
hydrogen bond with the Y72 amide backbone, which directs the Cβ hydrogen of serine to face towards the 
heme (Figure 4a). Modeling of the active site structure of BOR-CF3 with a bound diazo compound 2 showed 
that this serine arrangement generates more space at the heme distal side to better accommodate the CF3 
group. As a result, diazo compound 2 can mainly be docked in one specific conformation in the BOR-CF3 
active site (Figure 4b). Intriguingly, this conformation is structurally analogous to the transition state for 
iron-carbene generation via N2 loss (Figure 4c). This result suggests that the active site environment of 
BOR-CF3 not only constrains the conformation of the trifluorodiazo alkane, but also promotes the formation 
of the iron-carbene intermediate by facilitating the interaction between the diazo compound and the heme 
iron center.    
 Figure 4. (a) Empty surface area in a representative snapshot obtained from MD trajectories of apo BOR-CF3 and the 
hydrogen bonding interactions between 75S and 72Y amide backbone (see also Figures S1 and S2 in the SI). (b) 
Binding pose of diazo substrate 2 bound into the active site of BOR-CF3, obtained from docking and constrained MD 
simulations (see Figure S3 and computational details in the SI). Direct comparison between the shape of the BOR-
CF3 active site and the docked diazo 2 shows the high complementarity achieved by evolution and introduction of 
V75S mutation. (c) Comparison of diazo 2 bound in the BOR-CF3 structure and the DFT-optimized model transition 
state (TS) geometry for formation of the iron porphyrin carbene (IPC) intermediate (see SI Figure S8). The diazo 2 in 
this binding pose represents a near attack conformation that leads to the transition state for the generation of the iron 
porphyrin carbene intermediate. 
 
            We further modeled the BOR-CF3-bound trifluoroalkyl-carbene intermediate 2b formed from diazo 
compound 2. MD simulations revealed that 2b can adopt two major conformations as shown in Figure 5a 
and 5b. The main difference between the two conformers is the slight rotation of the Fe–C bond, which is 
possible because no specific contacts between CF3 group and the protein stabilize one conformation over 
the other. Nonetheless, in both conformations, the CF3 group is pointing into the active site and the bulkier 
phenyl group lies between the M103D and Y44I side chains and is exposed to the solvent, in line with our 
original hypothesis. More interesting, both conformers of 2b expose the same pro-R face of the carbene 
intermediate to the empty volume generated in the active site, consistent with the observed R absolute 
configuration of product 2a. To better understand the interaction between the borane substrate 1 and the 
carbene intermediate 2b, we used DFT calculations to describe the transition state (TS) for B–H carbene 
insertion using a model iron porphyrin system (see SI for computational details). A structural comparison 
between this TS geometry and the structure of protein-bound carbene-intermediate 2b revealed that borane 
1 can be effectively accommodated in the empty volume of 2b where it can adopt a catalytically competent 
pose to reach the TS for C–B bond formation (TS-CB). In this reaction scheme, the newly introduced M99A 
and M100L mutations alter the conformational dynamics of the front loop and generate an appropriate 
binding pocket for borane substrate 1 in the carbene-bound enzyme, while the major role of M103D and 
Y44I is to facilitate binding of the diazo substrate and stabilize both the diazo and the carbene intermediate 
in this binding pose. Notably, in this interaction mode, the alkyl substituent R on the CF3-carbene 
intermediate should have little influence on how the borane substrate approaches the carbene intermediate, 
which explains the general high enantioselectivity exhibited by BOR-CF3 for most trifluorodiazo alkanes 
tested.  
     
 
Figure 5. (a) Overlay of snapshots extracted from a 500 µs MD trajectory of BOR-CF3-bound trifluoroalkyl-carbene 
intermediate 2b (see also Figures S4 and S5 in the SI). (b) Representative snapshots of the two main conformations 
explored by trifluoroalkyl-carbene intermediate 2b in BOR-CF3 during MD trajectories. Blue surface represents the 
inner void cavity generated in the protein active site next to the iron porphyrin carbene. (c) DFT-optimized transition 
state (TS) for B–H carbene insertion in a model system (see also Figure S7). Key distances and angles are given in Å 
and degrees. 
 
      In conclusion, we have developed a biocatalytic platform for synthesis of chiral α-CF3 organoborons. 
Using directed evolution, we created an active site in Rma cyt c that can host structurally diverse 
trifluorodiazo alkanes for highly enantioselective carbene B–H insertion reactions. The effects of beneficial 
mutations on the catalytic activities and conformational dynamics have been rationalized by computational 
modeling. These efforts have expanded the scope of carbene intermediates accessible to heme proteins and 




ASSOCIATED CONTENT  
Supporting Information  
Detailed experimental procedures, spectroscopic data for all new compounds, details for molecular 








†X.H. and M.G.-B. contributed equally to this work  
 
Notes 
†The authors declare no competing financial interests. 
 
ACKNOWLEDGMENT  
We thank Kai Chen, Zhijun Jia, and Russell Lewis for helpful discussions. This work was supported by 
National Institutes of Health, National Institute for General Medical Sciences, GM-124480 (to K.N.H.); 
Jacobs Institute for Molecular Engineering for Medicine at Caltech (F.H.A.); National Science Foundation 
Division of Molecular and Cellular Biosciences Grant MCB-1513007 (F.H.A.). X.H. is supported by an 
NIH pathway to independence award (grant K99GM129419). M.G.-B. thanks the Ramón Areces 
Foundation for a postdoctoral fellowship. Computational resources were provided by the University of 
California, Los Angeles Institute for Digital Research and Education and the Extreme Science and 




 (1) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V. Fluorine in medicinal chemistry. Chem. Soc. 
Rev. 2008, 37, 320-330. 
 (2) Meanwell, N. A. Fluorine and fluorinated motifs in the design and application of bioisosteres for drug 
design. J. Med. Chem. 2018, 61, 5822-5880. 
 (3) Liang, T.; Neumann, C. N.; Ritter, T. Introduction of fluorine and fluorine-containing functional groups. 
Angew. Chem. Int. Ed. 2013, 52, 8214-8264. 
 (4) Yang, X. Y.; Wu, T.; Phipps, R. J.; Toste, F. D. Advances in catalytic enantioselective fluorination, 
mono-, di-, and trifluoromethylation, and trifluoromethylthiolation reactions. Chem. Rev. 2015, 115, 826-
870. 
 (5) Walker, M. C.; Chang, M. C. Y. Natural and engineered biosynthesis of fluorinated natural products. 
Chem. Soc. Rev. 2014, 43, 6527-6536. 
 (6) O'Hagan, D.; Deng, H. Enzymatic fluorination and biotechnological developments of the fluorinase. 
Chem. Rev. 2015, 115, 634-649. 
 (7) Thuronyi, B. W.; Chang, M. C. Y. Synthetic biology approaches to fluorinated polyketides. Acc. Chem. 
Res. 2015, 48, 584-592. 
 (8) Thuronyi, B. W.; Privalsky, T. M.; Chang, M. C. Y. Engineered fluorine metabolism and fluoropolymer 
production in living cells. Angew. Chem. Int. Ed. 2017, 56, 13637-13640. 
 (9) Thompson, S.; Zhang, Q.; Onega, M.; McMahon, S.; Fleming, I.; Ashworth, S.; Naismith, J. H.; 
Passchier, J.; O'Hagan, D. A localized tolerance in the substrate specificity of the fluorinase enzyme enables 
“last-step” 18F fluorination of a RGD peptide under ambient aqueous conditions. Angew. Chem. Int. Ed. 
2014, 53, 8913-8918. 
 (10) Eustaquio, A. S.; O'Hagan, D.; Moore, B. S. Engineering fluorometabolite production: fluorinase 
expression in Salinispora tropica yields fluorosalinosporamide. J. Nat. Prod. 2010, 73, 378-382. 
 (11) Walker, M. C.; Thuronyi, B. W.; Charkoudian, L. K.; Lowry, B.; Khosla, C.; Chang, M. C. Y. 
Expanding the fluorine chemistry of living systems using engineered polyketide synthase pathways. Science 
2013, 341, 1089-1094. 
 (12) Weeks, A. M.; Wang, N.; Pelton, J. G.; Chang, M. C. Y. Entropy drives selective fluorine recognition 
in the fluoroacetyl-CoA thioesterase from Streptomyces cattleya. Proc. Natl. Acad. Sci. U. S. A. 2018, 115, 
E2193-E2201. 
 (13) McMurry, J. L.; Chang, M. C. Y. Fluorothreonyl-tRNA deacylase prevents mistranslation in the 
organofluorine producer Streptomyces cattleya. Proc. Natl. Acad. Sci. U. S. A. 2017, 114, 11920-11925. 
 (14) Arnold, F. H. Directed evolution: bringing new chemistry to life. Angew. Chem. Int. Ed. 2018, 57, 
4143-4148. 
 (15) Prier, C. K.; Arnold, F. H. Chemomimetic Biocatalysis: Exploiting the Synthetic Potential of Cofactor-
Dependent Enzymes To Create New Catalysts. J. Am. Chem. Soc. 2015, 137, 13992-14006. 
 (16) Brandenberg, O. F.; Fasan, R.; Arnold, F. H. Exploiting and engineering hemoproteins for abiological 
carbene and nitrene transfer reactions. Curr. Opin. Biotechnol. 2017, 47, 102-111. 
 (17) Khersonsky, O.; Tawfik, D. S. Enzyme Promiscuity: A Mechanistic and Evolutionary Perspective. 
Annu. Rev. Biochem. 2010, 79, 471-505. 
 (18) Khersonsky, O.; Roodveldt, C.; Tawfik, D. S. Enzyme promiscuity: evolutionary and mechanistic 
aspects. Curr. Opin. Chem. Biol. 2006, 10, 498-508. 
 (19) Molander, G. A.; Ryu, D. Diastereoselective synthesis of vicinally bis(trifluoromethylated) alkylboron 
compounds through successive insertions of 2,2,2-trifluorodiazoethane. Angew. Chem. Int. Ed. 2014, 53, 
14181-14185. 
 (20) Argintaru, O. A.; Ryu, D.; Aron, I.; Molander, G. A. Synthesis and applications of α-
trifluoromethylated alkylboron compounds. Angew. Chem. Int. Ed. 2013, 52, 13656-13660. 
 (21) Jiang, Q.; Guo, T.; Yu, Z. Copper-catalyzed asymmetric borylation: construction of a stereogenic 
carbon center bearing both CF3 and organoboron functional groups. J. Org. Chem. 2017, 82, 1951-1960. 
 (22) Fyfe, J. W. B.; Watson, A. J. B. Recent developments in organoboron chemistry: old dogs, new tricks. 
Chem 2017, 3, 31-55. 
 (23) Ryu, D.; Primer, D. N.; Tellis, J. C.; Molander, G. A. Single-electron transmetalation: synthesis of 
1,1-diaryl-2,2,2-trifluoroethanes by photoredox/nickel dual catalytic cross-coupling. Chem.-Eur. J. 2016, 
22, 120-123. 
 (24) Sandford, C.; Aggarwal, V. K. Stereospecific functionalizations and transformations of secondary and 
tertiary boronic esters. Chem. Commun. 2017, 53, 5481-5494. 
 (25) Hyde, S.; Veliks, J.; Liégault, B.; Grassi, D.; Taillefer, M.; Gouverneur, V. Copper-catalyzed insertion 
into heteroatom–hydrogen bonds with trifluorodiazoalkanes. Angew. Chem. Int. Ed. 2016, 55, 3785-3789. 
 (26) Shi, G.; Xu, Y. A facile synthesis of α-trifluorodiazo compounds. J. Fluorine Chem. 1990, 46, 173-
178. 
 (27) Wang, J. B.; Li, G.; Reetz, M. T. Enzymatic site-selectivity enabled by structure-guided directed 
evolution. Chem. Commun. 2017, 53, 3916-3928. 
 (28) Brandenberg, O. F.; Prier, C. K.; Chen, K.; Knight, A. M.; Wu, Z.; Arnold, F. H. Stereoselective 
enzymatic synthesis of heteroatom-substituted cyclopropanes. ACS Catal. 2018, 2629-2634. 
 (29) Hernandez, K. E.; Renata, H.; Lewis, R. D.; Kan, S. B. J.; Zhang, C.; Forte, J.; Rozzell, D.; McIntosh, 
J. A.; Arnold, F. H. Highly stereoselective biocatalytic synthesis of key cyclopropane intermediate to 
ticagrelor. ACS Catal. 2016, 6, 7810-7813. 
 (30) Knight, A. M.; Kan, S. B. J.; Lewis, R. D.; Brandenberg, O. F.; Chen, K.; Arnold, F. H. Diverse 
engineered heme proteins enable stereodivergent cyclopropanation of unactivated alkenes. ACS Cent. Sci. 
2018, 4, 372-377. 
 (31) Coelho, P. S.; Wang, Z. J.; Ener, M. E.; Baril, S. A.; Kannan, A.; Arnold, F. H.; Brustad, E. M. A 
serine-substituted P450 catalyzes highly efficient carbene transfer to olefins in vivo. Nat. Chem. Biol. 2013, 
9, 485-487. 
 (32) Coelho, P. S.; Brustad, E. M.; Kannan, A.; Arnold, F. H. Olefin cyclopropanation via carbene transfer 
catalyzed by engineered cytochrome P450 enzymes. Science 2013, 339, 307-310. 
 (33) Kan, S. B. J.; Huang, X.; Gumulya, Y.; Chen, K.; Arnold, F. H. Genetically programmed chiral 
organoborane synthesis. Nature 2017, 552, 132-136. 
 (34) Kan, S. B. J.; Lewis, R. D.; Chen, K.; Arnold, F. H. Directed evolution of cytochrome c for carbon–
silicon bond formation: Bringing silicon to life. Science 2016, 354, 1048-1051. 
 (35) Yang, H.; Swartz, A. M.; Park, H. J.; Srivastava, P.; Ellis-Guardiola, K.; Upp, D. M.; Lee, G.; Belsare, 
K.; Gu, Y.; Zhang, C.; Moellering, R. E.; Lewis, J. C. Evolving artificial metalloenzymes via random 
mutagenesis. Nat. Chem. 2018, 10, 318-324. 
 (36) Srivastava, P.; Yang, H.; Ellis-Guardiola, K.; Lewis, J. C. Engineering a dirhodium artificial 
metalloenzyme for selective olefin cyclopropanation. Nat. Commun. 2015, 6, 7789. 
 (37) Bajaj, P.; Sreenilayam, G.; Tyagi, V.; Fasan, R. Gram-scale synthesis of chiral cyclopropane-
containing drugs and drug precursors with engineered myoglobin catalysts featuring complementary 
stereoselectivity. Angew. Chem. Int. Ed. 2016, 16110-16114. 
 (38) Bordeaux, M.; Tyagi, V.; Fasan, R. Highly Diastereoselective and Enantioselective Olefin 
Cyclopropanation Using Engineered Myoglobin-Based Catalysts. Angew. Chem. Int. Ed. 2015, 54, 1744-
1748. 
 (39) Tyagi, V.; Fasan, R. Myoglobin-catalyzed olefination of aldehydes. Angew. Chem. Int. Ed. 2016, 55, 
2512-2516. 
 (40) Sreenilayam, G.; Fasan, R. Myoglobin-catalyzed intermolecular carbene N-H insertion with arylamine 
substrates. Chem. Commun. 2015, 51, 1532-1534. 
 (41) Tinoco, A.; Steck, V.; Tyagi, V.; Fasan, R. Highly diastereo- and enantioselective synthesis of 
trifluoromethyl-substituted cyclopropanes via myoglobin-catalyzed transfer of trifluoromethylcarbene. J. 
Am. Chem. Soc. 2017, 139, 5293-5296. 
 (42) Dydio, P.; Key, H. M.; Nazarenko, A.; Rha, J. Y.-E.; Seyedkazemi, V.; Clark, D. S.; Hartwig, J. F. 
An artificial metalloenzyme with the kinetics of native enzymes. Science 2016, 354, 102-106. 
 (43) Key, H. M.; Dydio, P.; Clark, D. S.; Hartwig, J. F. Abiological catalysis by artificial haem proteins 
containing noble metals in place of iron. Nature 2016, 534, 534-537. 
 (44) Pang, Y.; He, Q.; Li, Z.-Q.; Yang, J.-M.; Yu, J.-H.; Zhu, S.-F.; Zhou, Q.-L. Rhodium-catalyzed B–H 
bond insertion reactions of unstabilized diazo compounds generated in situ from tosylhydrazones. J. Am. 
Chem. Soc. 2018, ASAP. 
 (45) Yang, J.-M.; Li, Z.-Q.; Li, M.-L.; He, Q.; Zhu, S.-F.; Zhou, Q.-L. Catalytic B–H bond insertion 
reactions using alkynes as carbene precursors. J. Am. Chem. Soc. 2017, 139, 3784-3789. 
 (46) Chen, D.; Zhang, X.; Qi, W.-Y.; Xu, B.; Xu, M.-H. Rhodium(I)-catalyzed asymmetric carbene 
insertion into B–H bonds: highly enantioselective access to functionalized organoboranes. J. Am. Chem. 
Soc. 2015, 137, 5268-5271. 
 (47) Allen, T. H.; Kawamoto, T.; Gardner, S.; Geib, S. J.; Curran, D. P. N-Heterocyclic carbene boryl 
iodides catalyze insertion reactions of N-heterocyclic carbene boranes and diazoesters. Org. Lett. 2017, 19, 
3680-3683. 
 (48) Li, X.; Curran, D. P. Insertion of reactive rhodium carbenes into boron–hydrogen bonds of stable N-
heterocyclic carbene boranes. J. Am. Chem. Soc. 2013, 135, 12076-12081. 
 (49) Cheng, Q.-Q.; Zhu, S.-F.; Zhang, Y.-Z.; Xie, X.-L.; Zhou, Q.-L. Copper-catalyzed B–H bond insertion 
reaction: a highly efficient and enantioselective C–B bond-forming reaction with amine–borane and 
phosphine–borane adducts. J. Am. Chem. Soc. 2013, 135, 14094-14097. 
 (50) Yang, J.-M.; Zhao, Y.-T.; Li, Z.-Q.; Gu, X.-S.; Zhu, S.-F.; Zhou, Q.-L. Gold-catalyzed oxidative 
coupling of terminal alkynes and borane adducts: efficient synthesis of α-boryl ketones. ACS Catal. 2018, 
8, 7351-7355. 
 (51) Stelter, M.; Melo, A. M. P.; Pereira, M. M.; Gomes, C. M.; Hreggvidsson, G. O.; Hjorleifsdottir, S.; 
Saraiva, L. M.; Teixeira, M.; Archer, M. A novel type of monoheme cytochrome c: biochemical and 
structural characterization at 1.23 Å resolution of Rhodothermus marinus cytochrome c. Biochemistry 2008, 
47, 11953-11963. 
 (52) Lewis, R. D.; Garcia-Borras, M.; Chalkley, M. J.; Buller, A. R.; Houk, K. N.; Kan, S. B. J.; Arnold, 
F. H. Catalytic iron-carbene intermediate revealed in a cytochrome c carbene transferase. Proc. Natl. Acad. 
Sci. U. S. A. 2018, 115, 7308-7313. 
 (53) Wiedemann, J.; Heiner, T.; Mloston, G.; Prakash, G. K. S.; Olah, G. A. Direct preparation of 
trifluoromethyl ketones from carboxylic esters: trifluoromethylation with (trifluoromethyl)trimethylsilane. 
Angew. Chem. Int. Ed. 1998, 37, 820-821. 
 (54) Bégué, J.-P.; Bonnet-Delpon, D. Preparation of trifluoromethyl ketones and related fluorinated 
ketones. Tetrahedron 1991, 47, 3207-3258. 
 (55) Matsuda, Y.; Abe, I. Biosynthesis of fungal meroterpenoids. Nat. Prod. Rep. 2016, 33, 26-53. 
 
